Literature DB >> 3350133

Lack of effect of dihydroergotamine on endothelial and smooth muscle cell proliferation and endothelial cell prostanoid production.

B Lindblad1, W E Burkel, T W Wakefield, L M Graham, J C Stanley.   

Abstract

The most important effect of dihydroergotamine is venoconstriction, but certain metabolic effects and changes in vessel prostanoid activity have also been suggested. In this study endothelial cell production of 6-keto PGF1 alpha and TxB2 was quantitated in vitro. No evidence of altered prostanoid production was noted after incubation with dihydroergotamine (exposure ranging from 5 x 10(-3) to 5 x 10(-7) g/l). Similarly, no effect of dihydroergotamine on the growth rates of endothelial cells or smooth muscle cells in vitro was documented.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3350133     DOI: 10.1007/bf01941713

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  8 in total

1.  A rapid, solid phase radioimmunoassay for prostaglandin F2alpha and its main circulating metabolite.

Authors:  F A Fitzpatrick; M A Wynalda
Journal:  Anal Biochem       Date:  1976-05-21       Impact factor: 3.365

2.  The effect of dihydroergotamine on various platelet function tests and venous prostacyclin-formation in men.

Authors:  H Sinzinger
Journal:  Thromb Haemost       Date:  1985-04-22       Impact factor: 5.249

3.  Changes in peripheral haemodynamics induced by dextran 70, dihydroergotamine, and their combination. A study using ultrasonic, serial phlebography, plethysmography and isotope clearance techniques.

Authors:  B Lindblad; D Bergqvist; H O Efsing; T Hallböök; S E Lindell
Journal:  Vasa       Date:  1984       Impact factor: 1.961

4.  Isolation of adult canine venous endothelium for tissue culture.

Authors:  J W Ford; W E Burkel; R H Kahn
Journal:  In Vitro       Date:  1981-01

5.  Enhanced prostaglandin synthesis contributes to the venoconstrictor activity of ergotamine.

Authors:  E Müller-Schweinitzer; J Brundell
Journal:  Blood Vessels       Date:  1975

6.  Investigations on the mode of action of ergotamine in the isolated femoral vein of the dog.

Authors:  E Müller-Schweinitzer; E Stürmer
Journal:  Br J Pharmacol       Date:  1974-07       Impact factor: 8.739

7.  The role of the prostanoid system in mediating the haemodynamic effects of dihydroergotamine.

Authors:  D Bergqvist; B Lindblad
Journal:  Ups J Med Sci       Date:  1984       Impact factor: 2.384

8.  [Influence of the venous wall--platelet interaction by dihydroergotamine (author's transl)].

Authors:  K Silberbauer; P Fitscha; H Sinzinger
Journal:  Wien Klin Wochenschr       Date:  1981-10-02       Impact factor: 1.704

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.